{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-22-026792","form_type":"8-K","ticker":"AMS","cik":"0000744825","company_name":"AMERICAN SHARED HOSPITAL SERVICES","filed_at":"2022-11-10T23:59:59+00:00","discovered_at":"2026-05-14T18:03:53.477451+00:00","generated_at":"2026-06-22T00:18:44.957988+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"American Shared Hospital Services Q3 revenue up 18% to $4.8M; net income $0.05 per share vs $0.01","bullets":["Revenue $4.828M (+17.8% YoY); net income $316K ($0.05 diluted EPS) vs $33K ($0.01) prior year.","Gross margin $1.957M (40.5% of revenue), +33.4% YoY; operating income $448K (+140.9%).","PBRT revenue up 82.4% to $2.358M; Gamma Knife same-center revenue down 12.5%.","Cash $11.664M at Sep 30, 2022; unused credit line of $7M.","Appointed Peter Gaccione as COO in September 2022."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-22-026792","json":"https://secwatch.observer/filing/0001437749-22-026792.json","markdown":"https://secwatch.observer/filing/0001437749-22-026792.md","text":"https://secwatch.observer/filing/0001437749-22-026792.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/744825/000143774922026792/0001437749-22-026792-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/744825/000143774922026792/asha20221109_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-22T00:18:44.957988+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"d60f9f708785e1ed90ded5924971b83260c7769a","claim":"AMERICAN SHARED HOSPITAL SERVICES reported third quarter and nine months of fiscal 2022, ended September 30, 2022 results: revenue $4,828,000, net income $316,000, or $0.05 per diluted share, EPS $0.05 per diluted share.","evidence_excerpt":"results for the third quarter and nine months of fiscal 2022, ended September 30, 2022. Third Quarter 2022 Financial Highlights ● Total revenue in the third quarter was $4,828,000, an increase of 17.8% from the comparable period in 2021. Total proton therapy revenue and fractions increased 82.4% and 40.1%, respectively, period-over-period. Gamma Knife","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/744825/000143774922026792/0001437749-22-026792-index.htm","confidence":0.98,"family_label":"Earnings Releases","details":[{"label":"Period","value":"third quarter and nine months of fiscal 2022, ended September 30, 2022"},{"label":"Revenue","value":"$4,828,000"},{"label":"Net income","value":"$316,000, or $0.05 per diluted share"},{"label":"EPS","value":"$0.05 per diluted share"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}